It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian.Īll problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the Yellow Card Scheme. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. Children and young people under 16 years who need IV fluid therapy, their families and carers.Commissioners and providers of healthcare services.
Healthcare professionals who care for children and young people who need IV fluid therapy.managing hypernatraemia and hyponatraemia that develops during intravenous fluid therapy.principles and protocols for intravenous fluid therapy.This guideline includes recommendations on: In June 2020, we amended a recommendation to clarify the use of isotonic crystalloids for routine maintenance in term neonates. This guideline represents a major opportunity to improve patient safety for children and young people having IV fluid therapy in hospital. It does not include recommendations relating to specific conditions. It applies to a range of conditions and different settings. This guideline covers general principles for managing intravenous (IV) fluids for children and young people under 16 years, including assessing fluid and electrolyte status and prescribing IV fluid therapy.
0 kommentar(er)
